Skip to content

Based on the various causes of ugly ferdox, it‘’s form in the study of radiotherapy for the treatment of diseases of nasopharyngeal carcinoma

Based on the various causes of ugly ferdox, it‘’s form in the study of radiotherapy for the treatment of diseases of nasopharyngeal carcinoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111973
Enrollment
Unknown
Registered
2025-11-07
Start date
2023-06-17
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma

Interventions

Experimental group:Symptom management, symptom monitoring, symptom warning and symptom intervention based on PRO were used in the experimental group
Control group:The control group received routine care and PRO symptom monitoring at the same time node. Patients only filled in the scale without triggering early warning, and patients reported themse

Sponsors

The First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.A newly diagnosed patient with nasopharyngeal carcinoma diagnosed by pathological examination 2.Age 18-70 3.Participate voluntarily and sign informed consent 4.Image-guided intensity modulated radiotherapy (IMRT) was used to receive 6MV-X irradiation, and the total dose of radiotherapy for primary nasopharyngeal lesions was 68-72Gy, 2-2.2Gy/times, 5 times/week, a total of 30-33 times.

Exclusion criteria

Exclusion criteria: 1. Disorder of consciousness or history of mental illness 2. Abnormal communication and cognitive function, no ability to fill in the scale 3.Complications with other tumors 4. Complicated heart, liver, kidney and other organ dysfunction

Design outcomes

Primary

MeasureTime frame
fatigue;

Secondary

MeasureTime frame
xerostomia;Oral mucositis;pain;

Countries

China

Contacts

Public ContactLong Xiaoli

The First Affiliated Hospital of the Air Force Medical University (Xijing Hospital)

longxl@fmmu.edu.cn+86 139 9183 3378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026